SUI DeSci Agents democratizes longevity research investment through DeSci platform.
From Investing.com
December 31, 2024 09:30:35 AM:
Decentralized Science (DeSci) by SUI Desci Agents targets inefficiencies in traditional research, offering retail access to longevity investments. BIO Protocol’s Binance listing on January 3, 2025, allows users to stake BNB and FDUSD for BIO airdrops. SUI Desci Agents pairs AI agents with compounds to democratize longevity research investment.
The number of DeSci supporters grows, with Vitalik Buterin, Brian Armstrong, A16Z, and Pfizer Ventures backing various projects. pump.science’s Rifampicin and Urolithin A tokens reached market caps of $125M and $45M, respectively. SUI Desci Agents leads in DeSci, enabling retail investment in tokenized compounds and wellness tools.
$DESCI contributes to scientific innovation as interest in decentralized science rises. SUI DeSci Agents aims to democratize longevity research investments, utilizing AI agents and liquidity mechanics. Contact CEO Olha Zubarieva for further information on the platform’s initiatives.
Read more at Investing.com: SUI DeSci Agents Launches a Platform to Democratize Longevity Amid DeSci Boom By Chainwire